These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34372920)

  • 1. A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants.
    Pandi MT; Koromina M; Tsafaridis I; Patsilinakos S; Christoforou E; van der Spek PJ; Patrinos GP
    Hum Genomics; 2021 Aug; 15(1):51. PubMed ID: 34372920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics.
    Tafazoli A; Mikros J; Khaghani F; Alimardani M; Rafigh M; Hemmati M; Siamoglou S; Golińska AK; Kamiński KA; Niemira M; Miltyk W; Patrinos GP
    Hum Genomics; 2023 Jul; 17(1):62. PubMed ID: 37452347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
    Zhou Y; Mkrtchian S; Kumondai M; Hiratsuka M; Lauschke VM
    Pharmacogenomics J; 2019 Apr; 19(2):115-126. PubMed ID: 30206299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
    Zhou Y; Pirmann S; Lauschke VM
    Pharmacogenomics J; 2024 May; 24(3):17. PubMed ID: 38802404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning random forest for predicting oncosomatic variant NGS analysis.
    Pellegrino E; Jacques C; Beaufils N; Nanni I; Carlioz A; Metellus P; Ouafik L
    Sci Rep; 2021 Nov; 11(1):21820. PubMed ID: 34750410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction.
    Chen ML; Doddi A; Royer J; Freschi L; Schito M; Ezewudo M; Kohane IS; Beam A; Farhat M
    EBioMedicine; 2019 May; 43():356-369. PubMed ID: 31047860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.
    Choi J; Tantisira KG; Duan QL
    Pharmacogenomics J; 2019 Apr; 19(2):127-135. PubMed ID: 30214008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives.
    Brlek P; Bulić L; Bračić M; Projić P; Škaro V; Shah N; Shah P; Primorac D
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. parSMURF, a high-performance computing tool for the genome-wide detection of pathogenic variants.
    Petrini A; Mesiti M; Schubach M; Frasca M; Danis D; Re M; Grossi G; Cappelletti L; Castrignanò T; Robinson PN; Valentini G
    Gigascience; 2020 May; 9(5):. PubMed ID: 32444882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics.
    Pandi MT; Williams MS; van der Spek P; Koromina M; Patrinos GP
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.
    Spinella JF; Mehanna P; Vidal R; Saillour V; Cassart P; Richer C; Ouimet M; Healy J; Sinnett D
    BMC Genomics; 2016 Nov; 17(1):912. PubMed ID: 27842494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Need for Precision Medicine to be Applied to Diabetes.
    Klonoff DC; Florez JC; German M; Fleming A
    J Diabetes Sci Technol; 2020 Nov; 14(6):1122-1128. PubMed ID: 31903769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
    Nono AD; Chen K; Liu X
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LEAP: Using machine learning to support variant classification in a clinical setting.
    Lai C; Zimmer AD; O'Connor R; Kim S; Chan R; van den Akker J; Zhou AY; Topper S; Mishne G
    Hum Mutat; 2020 Jun; 41(6):1079-1090. PubMed ID: 32176384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRlncRC: a machine learning-based method for cancer-related long noncoding RNA identification using integrated features.
    Zhang X; Wang J; Li J; Chen W; Liu C
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):120. PubMed ID: 30598114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics.
    Siamoglou S; Koromina M; Hishinuma E; Yamazaki S; Tsermpini EE; Kordou Z; Fukunaga K; Chantratita W; Zhou Y; Lauschke VM; Mushiroda T; Hiratsuka M; Patrinos GP
    Pharmacol Res; 2022 Feb; 176():106087. PubMed ID: 35033648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine.
    Salleh MZ; Teh LK; Lee LS; Ismet RI; Patowary A; Joshi K; Pasha A; Ahmed AZ; Janor RM; Hamzah AS; Adam A; Yusoff K; Hoh BP; Hatta FH; Ismail MI; Scaria V; Sivasubbu S
    PLoS One; 2013; 8(8):e71554. PubMed ID: 24009664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pipeline design to identify key features and classify the chemotherapy response on lung cancer patients using large-scale genetic data.
    Valdés MG; Galván-Femenía I; Ripoll VR; Duran X; Yokota J; Gavaldà R; Rafael-Palou X; de Cid R
    BMC Syst Biol; 2018 Nov; 12(Suppl 5):97. PubMed ID: 30458782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.